Literature DB >> 3197982

Effect of intragastric pH on mucosal protective action of sucralfate.

J Z Danesh1, A Duncan, R I Russell, G Mitchell.   

Abstract

Acid intragastric pH is believed to be mandatory for mucosal protective action of sucralfate, but evidence for its efficacy at neutral pH is lacking. The effect of sucralfate on gastric mucosal erosions induced by oral administration of aspirin and bile acids at acidic pH of 1.5 and 3.9, and near neutral pH of 6.5 was investigated in 320 rats. The effect of sucralfate on the intragastric pH four hours after the ingestion of test solutions was also examined. The incidence and severity of mucosal erosions induced by aspirin and bile acids were lower in animals treated with sucralfate at acidic (p less than 0.001) and near neutral (p less than 0.01) intragastric pH. Mucosal protection was greater with ingestion of sucralfate 300 mg/kg and 200 mg/kg, than with 100 mg/kg. The intragastric pH was higher (p less than 0.001) in sucralfate treated groups at pH 3.9 and 6.5. This study provides evidence that sucralfate protects against mucosal injury at near neutral, as well as at acidic pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197982      PMCID: PMC1434010          DOI: 10.1136/gut.29.10.1379

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Aspirin and gastric bleeding. Gastroscopic observations, with review of literature.

Authors:  A WEISS; E R PITMAN; E C GRAHAM
Journal:  Am J Med       Date:  1961-08       Impact factor: 4.965

2.  Rapid determination of salicylate in biological fluids.

Authors:  P TRINDER
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

3.  "Buffering" activity of sucralfate.

Authors:  M Guslandi
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

4.  Prevention of aspirin-induced gastric ulceration by bile duct or pylorus ligation in the rat.

Authors:  B Djahanguiri; F S Abtahi; M Hemmati
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

5.  Increased reflux of bile into the stomach in patients with gastric ulcer.

Authors:  J Rhodes; D E Barnardo; S F Phillips; R A Rovelstad; A F Hofmann
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

6.  Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcers. A double-blind, placebo-controlled trial.

Authors:  G M Van Deventer; D Schneidman; J H Walsh
Journal:  Am J Med       Date:  1985-08-30       Impact factor: 4.965

7.  Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.

Authors:  S J Konturek; T Radecki; I Piastucki; T Brzozowski; D Drozdowicz
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

8.  Sucralfate and gastric bicarbonate.

Authors:  M Guslandi
Journal:  Pharmacology       Date:  1985       Impact factor: 2.547

9.  Gastric protection by sucralfate. Role of mucus and prostaglandins.

Authors:  T Shea-Donohue; L Steel; E Montcalm; A Dubois
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

10.  Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.

Authors:  S J Konturek; N Kwiecień; W Obtułowicz; B Kopp; J Oleksy
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

View more
  2 in total

1.  Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture.

Authors:  M Romano; M Razandi; K J Ivey
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluating cytoprotective agents.

Authors:  A S Tang; P J Chikhale; P K Shah; R T Borchardt
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.